Literature DB >> 31843998

Whole-Genome Approach to Understanding the Mechanism of Action of a Histatin 5-Derived Peptide.

Cody B Bullock1, David S McNabb1,2, Inés Pinto3,2.   

Abstract

The incidence of opportunistic fungal infections that threaten immunocompromised patients, along with the limited arsenal of antifungal drugs, calls for renewed efforts to develop novel antifungal therapies. Antimicrobial peptides have garnered interest as potential therapeutics. Among naturally occurring peptides, histatin 5 is a well-characterized 24-amino-acid peptide with strong antifungal activity. Our lab has identified a smaller histatin derivative, KM29, with stronger activity against multiple Candida spp., prompting us to investigate its fungicidal mechanism. A genetic screen was developed to test the Saccharomyces cerevisiae genomewide deletion collection for mutants with increased or decreased peptide sensitivity. The goal was to identify genes that would reveal insights into the mechanism of action of KM29, to be assessed in Candida albicans Several biological processes yielded increased sensitivity, with endosomal transport and vacuolar function appearing at high frequencies. Among the pathways involved in increased resistance, mitochondrial function showed the highest normalized genome frequency; hence, we focused on characterizing this pathway. KM29 localizes to mitochondria, and the killing activity depends on a functional electron transport chain. In addition, KM29 triggered reactive oxygen species (ROS) production, which was responsible for some cell death but insufficient to account for the complete killing activity. In agreement with this finding, we found that KM29 induced mitochondrial fragmentation and a mild loss of mitochondrial membrane potential. Furthermore, respiratory mutants exhibited severely diminished KM29 uptake. We confirmed this behavior in a C. albicans respiratory mutant. Taking our findings together, this work delineates the mitochondrial functions associated with KM29 fungicidal activity and provides additional pathways for further characterization in Candida spp.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Candida; antimicrobial peptide; fungal pathogenesis

Mesh:

Substances:

Year:  2020        PMID: 31843998      PMCID: PMC7038261          DOI: 10.1128/AAC.01698-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  59 in total

Review 1.  Peptide antimicrobial agents.

Authors:  Håvard Jenssen; Pamela Hamill; Robert E W Hancock
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

Review 2.  Mitochondria and fungal pathogenesis: drug tolerance, virulence, and potential for antifungal therapy.

Authors:  Miguel Shingu-Vazquez; Ana Traven
Journal:  Eukaryot Cell       Date:  2011-09-16

3.  Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates.

Authors:  M E Kuipers; H G de Vries; M C Eikelboom; D K Meijer; P J Swart
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

4.  The cellular target of histatin 5 on Candida albicans is the energized mitochondrion.

Authors:  E J Helmerhorst; P Breeuwer; W van't Hof; E Walgreen-Weterings; L C Oomen; E C Veerman; A V Amerongen; T Abee
Journal:  J Biol Chem       Date:  1999-03-12       Impact factor: 5.157

Review 5.  Mitochondria and mitophagy: the yin and yang of cell death control.

Authors:  Dieter A Kubli; Åsa B Gustafsson
Journal:  Circ Res       Date:  2012-10-12       Impact factor: 17.367

6.  Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro.

Authors:  Mark R Harris; Peter J Coote
Journal:  Int J Antimicrob Agents       Date:  2010-01-27       Impact factor: 5.283

Review 7.  Membrane trafficking in the yeast Saccharomyces cerevisiae model.

Authors:  Serge Feyder; Johan-Owen De Craene; Séverine Bär; Dimitri L Bertazzi; Sylvie Friant
Journal:  Int J Mol Sci       Date:  2015-01-09       Impact factor: 5.923

Review 8.  Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species.

Authors:  Sarah G Whaley; Elizabeth L Berkow; Jeffrey M Rybak; Andrew T Nishimoto; Katherine S Barker; P David Rogers
Journal:  Front Microbiol       Date:  2017-01-12       Impact factor: 5.640

Review 9.  Fluconazole resistance in Candida species: a current perspective.

Authors:  Elizabeth L Berkow; Shawn R Lockhart
Journal:  Infect Drug Resist       Date:  2017-07-31       Impact factor: 4.003

Review 10.  Multiple applications of Alamar Blue as an indicator of metabolic function and cellular health in cell viability bioassays.

Authors:  Sephra N Rampersad
Journal:  Sensors (Basel)       Date:  2012-09-10       Impact factor: 3.576

View more
  2 in total

1.  In Vitro and In Vivo Anti-Candida Activity and Structural Analysis of Killer Peptide (KP)-Derivatives.

Authors:  Tecla Ciociola; Thelma A Pertinhez; Tiziano De Simone; Walter Magliani; Elena Ferrari; Silvana Belletti; Tiziana D'Adda; Stefania Conti; Laura Giovati
Journal:  J Fungi (Basel)       Date:  2021-02-10

2.  Salivary Histatin 5 Level in Women with Vaginal Candidiasis.

Authors:  İrem Şenyuva; Cansu Koca; Funda Karabag Çoban; Özgür Tarhan
Journal:  Int J Clin Pract       Date:  2022-06-27       Impact factor: 3.149

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.